1. Home
  2. FNWD vs PEPG Comparison

FNWD vs PEPG Comparison

Compare FNWD & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$36.51

Market Cap

147.7M

Sector

Finance

ML Signal

N/A

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$2.16

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
PEPG
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
121.7M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
FNWD
PEPG
Price
$36.51
$2.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$37.50
$11.17
AVG Volume (30 Days)
28.8K
1.1M
Earning Date
04-28-2026
05-14-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
25.61
EPS
0.52
N/A
Revenue
N/A
N/A
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$70.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$1.01
52 Week High
$39.99
$7.80

Technical Indicators

Market Signals
Indicator
FNWD
PEPG
Relative Strength Index (RSI) 62.65 58.03
Support Level $36.37 $1.47
Resistance Level $38.86 $2.62
Average True Range (ATR) 0.94 0.22
MACD -0.04 0.00
Stochastic Oscillator 33.66 46.55

Price Performance

Historical Comparison
FNWD
PEPG

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: